Kayne Anderson Rudnick Investment Management’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGN
GAM
Kayne Anderson Rudnick Investment Management's OGN Position: Q3 2025 in Review
Kayne Anderson Rudnick Investment Management sold out of Organon & Co (OGN) in Q3 2025, closing a stake of 36 shares — an estimated $348 sold.
Kayne Anderson Rudnick Investment Management first reported a position in OGN in Q2 2021 and held it in 14 quarters. The position peaked at $35K in Q1 2022. 670 funds tracked by Wall St. Rank hold OGN as of Q3 2025.
- Kayne Anderson Rudnick Investment Management reported no remaining Organon & Co position as of Q3 2025 after selling out during the quarter.
- Kayne Anderson Rudnick Investment Management sold 36 Organon & Co shares in Q3 2025, an estimated $348.
- Kayne Anderson Rudnick Investment Management first reported a position in Organon & Co in Q2 2021 and held it in 14 quarters.
- Kayne Anderson Rudnick Investment Management's Organon & Co position peaked at $35K in Q1 2022.
- 670 funds tracked by Wall St. Rank held Organon & Co as of Q3 2025.
Based on Kayne Anderson Rudnick Investment Management's 13F filing for Q3 2025, filed 13 Nov 2025.